143 related articles for article (PubMed ID: 22510373)
1. Relaxin improves TNF-α-induced endothelial dysfunction: the role of glucocorticoid receptor and phosphatidylinositol 3-kinase signalling.
Dschietzig T; Brecht A; Bartsch C; Baumann G; Stangl K; Alexiou K
Cardiovasc Res; 2012 Jul; 95(1):97-107. PubMed ID: 22510373
[TBL] [Abstract][Full Text] [Related]
2. Nectandrin B activates endothelial nitric-oxide synthase phosphorylation in endothelial cells: role of the AMP-activated protein kinase/estrogen receptor α/phosphatidylinositol 3-kinase/Akt pathway.
Hien TT; Oh WK; Nguyen PH; Oh SJ; Lee MY; Kang KW
Mol Pharmacol; 2011 Dec; 80(6):1166-78. PubMed ID: 21940786
[TBL] [Abstract][Full Text] [Related]
3. Diosgenin ameliorates palmitate-induced endothelial dysfunction and insulin resistance via blocking IKKβ and IRS-1 pathways.
Liu K; Zhao W; Gao X; Huang F; Kou J; Liu B
Atherosclerosis; 2012 Aug; 223(2):350-8. PubMed ID: 22766331
[TBL] [Abstract][Full Text] [Related]
4. Puerarin activates endothelial nitric oxide synthase through estrogen receptor-dependent PI3-kinase and calcium-dependent AMP-activated protein kinase.
Hwang YP; Kim HG; Hien TT; Jeong MH; Jeong TC; Jeong HG
Toxicol Appl Pharmacol; 2011 Nov; 257(1):48-58. PubMed ID: 21884717
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial function is improved by oral glycine treatment in aged rats.
Gómez-Zamudio JH; García-Macedo R; Lázaro-Suárez M; Ibarra-Barajas M; Kumate J; Cruz M
Can J Physiol Pharmacol; 2015 Jun; 93(6):465-73. PubMed ID: 25988540
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic studies of AVE3085 against homocysteine in endothelial protection.
Yang Q; Xue HM; Underwood MJ; Yu CM
Cardiovasc Drugs Ther; 2013 Dec; 27(6):511-20. PubMed ID: 23846330
[TBL] [Abstract][Full Text] [Related]
7. Celiprolol activates eNOS through the PI3K-Akt pathway and inhibits VCAM-1 Via NF-kappaB induced by oxidative stress.
Kobayashi N; Mita S; Yoshida K; Honda T; Kobayashi T; Hara K; Nakano S; Tsubokou Y; Matsuoka H
Hypertension; 2003 Nov; 42(5):1004-13. PubMed ID: 14557279
[TBL] [Abstract][Full Text] [Related]
8. Activation of eNOS in rat portal hypertensive gastric mucosa is mediated by TNF-alpha via the PI 3-kinase-Akt signaling pathway.
Kawanaka H; Jones MK; Szabo IL; Baatar D; Pai R; Tsugawa K; Sugimachi K; Sarfeh IJ; Tarnawski AS
Hepatology; 2002 Feb; 35(2):393-402. PubMed ID: 11826414
[TBL] [Abstract][Full Text] [Related]
9. Berberine protects endothelial progenitor cell from damage of TNF-α via the PI3K/AKT/eNOS signaling pathway.
Xiao M; Men LN; Xu MG; Wang GB; Lv HT; Liu C
Eur J Pharmacol; 2014 Nov; 743():11-6. PubMed ID: 25257463
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II type 1 receptor blockers prevent tumor necrosis factor-alpha-mediated endothelial nitric oxide synthase reduction and superoxide production in human umbilical vein endothelial cells.
Kataoka H; Murakami R; Numaguchi Y; Okumura K; Murohara T
Eur J Pharmacol; 2010 Jun; 636(1-3):36-41. PubMed ID: 20353766
[TBL] [Abstract][Full Text] [Related]
11. Serelaxin (recombinant human relaxin-2) prevents high glucose-induced endothelial dysfunction by ameliorating prostacyclin production in the mouse aorta.
Ng HH; Leo CH; Parry LJ
Pharmacol Res; 2016 May; 107():220-228. PubMed ID: 26993102
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alpha induces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinase-dependent pathway.
Li G; Barrett EJ; Barrett MO; Cao W; Liu Z
Endocrinology; 2007 Jul; 148(7):3356-63. PubMed ID: 17446186
[TBL] [Abstract][Full Text] [Related]
13. Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-Glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan.
Knorr M; Hausding M; Kröller-Schuhmacher S; Steven S; Oelze M; Heeren T; Scholz A; Gori T; Wenzel P; Schulz E; Daiber A; Münzel T
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2223-31. PubMed ID: 21757654
[TBL] [Abstract][Full Text] [Related]
14. Metastatic breast carcinoma induces vascular endothelial dysfunction in Balb-c mice: Role of the tumor necrosis factor-α and NADPH oxidase.
Dalaklioglu S; Tasatargil A; Kale S; Tanriover G; Dilmac S; Erin N
Vascul Pharmacol; 2013; 59(3-4):103-11. PubMed ID: 23933568
[TBL] [Abstract][Full Text] [Related]
15. Endothelial dysfunction in rat adjuvant-induced arthritis: up-regulation of the vascular arginase pathway.
Prati C; Berthelot A; Wendling D; Demougeot C
Arthritis Rheum; 2011 Aug; 63(8):2309-17. PubMed ID: 21484767
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of hyperhomocysteinemia-induced vascular endothelium dysfunction - possible dysregulation of phosphatidylinositol-3-kinase and its downstream phosphoinositide dependent kinase and protein kinase B.
Sharma S; Singh M; Sharma PL
Eur J Pharmacol; 2013 Dec; 721(1-3):365-72. PubMed ID: 24021535
[TBL] [Abstract][Full Text] [Related]
17. Endothelium-Dependent Relaxation Effect of Apocynum venetum Leaf Extract via Src/PI3K/Akt Signalling Pathway.
Lau YS; Ling WC; Murugan D; Kwan CY; Mustafa MR
Nutrients; 2015 Jun; 7(7):5239-53. PubMed ID: 26133970
[TBL] [Abstract][Full Text] [Related]
18. Arginase overexpression and NADPH oxidase stimulation underlie impaired vasodilation induced by advanced glycation end products.
El-Bassossy HM; Neamatallah T; Balamash KS; Abushareb AT; Watson ML
Biochem Biophys Res Commun; 2018 May; 499(4):992-997. PubMed ID: 29627571
[TBL] [Abstract][Full Text] [Related]
19. Endothelial nitric oxide synthase activation by tumor necrosis factor alpha through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors: a novel pathway relevant to the pathophysiology of endothelium.
De Palma C; Meacci E; Perrotta C; Bruni P; Clementi E
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):99-105. PubMed ID: 16269668
[TBL] [Abstract][Full Text] [Related]
20. Endothelial dysfunction in rat adjuvant-induced arthritis: vascular superoxide production by NAD(P)H oxidase and uncoupled endothelial nitric oxide synthase.
Haruna Y; Morita Y; Komai N; Yada T; Sakuta T; Tomita N; Fox DA; Kashihara N
Arthritis Rheum; 2006 Jun; 54(6):1847-55. PubMed ID: 16729278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
